Greenwich LifeSciences GLSI
NASDAQ GLSI
$16.09 +0.02 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Greenwich LifeSciences (GLSI) Long-Term Debt Repayments (2021 - 2022)

Updated

Greenwich LifeSciences (GLSI) recorded Long-Term Debt Repayments of $2.02 million in Q2 2022, down 63.3% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Long-Term Debt Repayments (2021 - 2022) Analysis & Trends

On a TTM basis, Greenwich LifeSciences' Long-Term Debt Repayments came in at $7.54 million as of Jun 30, 2022; for FY2020, it came in at $360,000.

  • The Q2 2022 figure is the lowest quarterly Long-Term Debt Repayments since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Greenwich LifeSciences 235.88 Mn 206.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 2.02 Mn
Mar 31, 2022 5.51 Mn
Mar 31, 2021 275,154.00
API Access

Greenwich LifeSciences Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=GLSI&period=max&api_key=YOUR_API_KEY